Item 16. Form 10-K Summary
6K characters. Original on sec.gov ·
Item 16. Form 10-K Summary
None.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
| LENNAR CORPORATION | ||||||||
| /S/ STUART MILLER | ||||||||
| Stuart Miller | ||||||||
| Executive Chairman and Chief Executive Officer | ||||||||
| Date: | January 28, 2026 |
Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:
| Principal Executive Officer: | ||||||||
| Stuart Miller | /S/ STUART MILLER | |||||||
| Executive Chairman, Chief Executive Officer and Director | Date: | January 28, 2026 | ||||||
| Principal Financial Officer: | ||||||||
| Diane Bessette | /S/ DIANE BESSETTE | |||||||
| Vice President and Chief Financial Officer | Date: | January 28, 2026 | ||||||
| Principal Accounting Officer: | ||||||||
| David Collins | /S/ DAVID COLLINS | |||||||
| Vice President and Controller | Date: | January 28, 2026 | ||||||
| Directors: | ||||||||
| Amy Banse | /S/ AMY BANSE | |||||||
| Date: | January 28, 2026 | |||||||
| Theron I. ("Tig") Gilliam, Jr. | /S/ THERON I. ("TIG") GILLIAM, JR. | |||||||
| Date: | January 28, 2026 | |||||||
| Sherrill W. Hudson | /S/ SHERRILL W. HUDSON | |||||||
| Date: | January 28, 2026 | |||||||
| Teri McClure | /S/ TERI MCCLURE | |||||||
| Date: | January 28, 2026 | |||||||
| Armando Olivera | /S/ ARMANDO OLIVERA | |||||||
| Date: | January 28, 2026 | |||||||
| Dacona Smith | /S/ DACONA SMITH | |||||||
| Date: | January 28, 2026 | |||||||
| Jeffrey Sonnenfeld | /S/ JEFFREY SONNENFELD | |||||||
| Date: | January 28, 2026 | |||||||
| Serena Wolfe | /S/ SERENA WOLFE | |||||||
| Date: | January 28, 2026 | |||||||
LENNAR CORPORATION AND SUBSIDIARIES
Schedule II—Valuation and Qualifying Accounts
Years Ended November 30, 2025, 2024 and 2023
| Additions | |||||||||||||||||||||||||||||
| (In thousands) | Beginning balance | Charged to costs and expenses | Charged (credited) to other accounts | Deductions | Ending balance | ||||||||||||||||||||||||
| Year ended November 30, 2025 | |||||||||||||||||||||||||||||
| Allowances deducted from assets to which they apply: | |||||||||||||||||||||||||||||
| Allowance for credit losses against notes and other receivables | $ | 2,399 | 907 | (2,477) | — | 829 | |||||||||||||||||||||||
| Allowance for loan losses against loans receivable | $ | 11,938 | 490 | 1,355 | (9,623) | 4,160 | |||||||||||||||||||||||
| Allowance against net deferred tax assets | $ | 2,593 | 7 | — | (54) | 2,546 | |||||||||||||||||||||||
| Year ended November 30, 2024 | |||||||||||||||||||||||||||||
| Allowances deducted from assets to which they apply: | |||||||||||||||||||||||||||||
| Allowance for credit losses against notes and other receivables | $ | 2,374 | 677 | (652) | — | 2,399 | |||||||||||||||||||||||
| Allowance for loan losses against loans receivable | $ | 15,414 | 174 | — | (3,650) | 11,938 | |||||||||||||||||||||||
| Allowance against net deferred tax assets | $ | 2,333 | 268 | — | (8) | 2,593 | |||||||||||||||||||||||
| Year ended November 30, 2023 | |||||||||||||||||||||||||||||
| Allowances deducted from assets to which they apply: | |||||||||||||||||||||||||||||
| Allowance for credit losses against notes and other receivables | $ | 2,179 | 274 | (79) | — | 2,374 | |||||||||||||||||||||||
| Allowance for loan losses against loans receivable | $ | 11,130 | 5,419 | — | (1,135) | 15,414 | |||||||||||||||||||||||
| Allowance against net deferred tax assets | $ | 2,903 | 89 | — | (659) | 2,333 |
Previous: Item 15. Exhibit and Financial Statement Schedules.
Sponsor Sponsor this sector. One slot per industry, shown on every filing in it. Details